Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS stud | |
Zhou, Q.; Zhang, H.; Jiang, L.; Shi, Y.; Chen, Y.; Yu, J.; Zhou, C.; He, Y.; Hu, Y.; Liang, Z-A. | |
2018 | |
会议名称 | ANNALS OF ONCOLOGY |
会议日期 | 2018-11-01 |
页码 | 158-158 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6349331 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhou, Q.,Zhang, H.,Jiang, L.,et al. Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS stud[C]. 见:ANNALS OF ONCOLOGY. 2018-11-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论